Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
PEN	PENUMBRA INC	$12.90B	12.30%	9.60%	12.03%	14.90%	0.29	6.02	67.40%	11.80%	13.96%
XLO	XILIO THERAPEUTICS INC	$51.30M	-117.20%	-21.40%	-25.97%	108.70%	1.25	3.59	100.00%	-58.50%	-58.52%
IONS	IONIS PHARMACEUTICALS INC	$12.52B	-58.60%	-10.10%	-8.60%	-6.10%	6.02	4.10	98.40%	-30.90%	-22.21%
PROF	PROFOUND MEDICAL CORP	$253.27M	-78.90%	-64.10%	-63.11%	-257.10%	0.24	6.56	71.10%	-206.80%	-210.83%
TAOX	TAO SYNERGIES INC	$35.27M	-134.10%	-109.50%	-83.05%	-152.70%	0.21	27.40	100.00%	-3,783.50%	-3,615.43%
KMDA	KAMADA LTD	$451.10M	7.70%	5.40%	7.15%	15.60%	0.48	3.33	41.20%	11.20%	12.72%
SGHT	SIGHT SCIENCES INC	$279.67M	-59.10%	-32.20%	-35.09%	-64.20%	1.04	5.86	86.20%	-46.80%	-40.38%
ODTX	ODYSSEY THERAPEUTICS INC	N/A	N/A	N/A	-61.47%	N/A	-0.11	7.20	100.00%	-4,994.90%	-5,025.44%
SNWV	SANUWAVE HEALTH INC	$144.03M	-450.60%	44.90%	112.15%	150.60%	19.18	1.31	76.70%	36.20%	47.55%
MGNX	MACROGENICS INC	$269.51M	-147.80%	-28.40%	-47.34%	-26.80%	9.28	1.90	74.40%	-44.80%	-36.75%
NRXS	NEURAXIS INC	$92.02M	-205.90%	-115.30%	-121.14%	604.80%	0.52	2.89	85.00%	-188.60%	-167.82%
MOVE	CORVEX INC	$48.46M	-12.70%	-11.70%	-2.55%	-147.40%	0.05	2.14	-190.80%	-2,475.60%	-2,031.07%
WRBY	WARBY PARKER INC	$3.01B	0.40%	0.20%	-1.05%	-1.20%	0.96	2.33	53.40%	0.20%	-0.69%
NVS	NOVARTIS AG	$289.57B	31.70%	12.30%	19.53%	34.00%	2.07	0.85	75.40%	23.90%	30.08%
PYPD	POLYPID LTD	$87.93M	-366.30%	-143.80%	-229.81%	-391.20%	1.03	1.97	N/A	N/A	N/A
ASMB	ASSEMBLY BIOSCIENCES INC	$421.15M	-4.20%	-3.10%	-3.18%	-5.10%	0.19	6.65	N/A	N/A	N/A
ANL	ADLAI NORTYE LTD	$461.94M	-414.00%	-67.20%	472.51%	547.00%	-5.14	0.65	100.00%	-710.60%	-679.94%
BCRX	BIOCRYST PHARMACEUTICALS INC	$2.13B	N/A	-97.30%	-140.55%	-44.00%	-1.84	1.91	97.80%	-51.70%	-42.79%
ALKS	ALKERMES PLC	$6.16B	8.80%	5.40%	6.48%	16.50%	1.43	2.27	86.60%	9.80%	15.18%
GMAB	GENMAB A	$17.38B	14.50%	8.50%	12.60%	34.20%	1.18	2.18	93.30%	21.00%	36.17%
YCBD	CBDMD INC	$8.18M	-39.30%	-28.10%	-28.77%	-64.90%	0.32	2.83	59.40%	-15.60%	-13.37%
ENLV	ENLIVEX LTD	$170.91M	248.10%	206.40%	69.81%	279.90%	0.20	193.24	N/A	N/A	N/A
CERT	CERTARA INC	$804.27M	-1.40%	-1.00%	1.11%	5.00%	0.48	1.88	61.60%	-3.60%	3.57%
CCCC	C4 THERAPEUTICS INC	$389.20M	-50.70%	-33.20%	-34.38%	-38.90%	0.40	9.01	100.00%	-297.80%	-297.41%
CYTK	CYTOKINETICS INC	$9.71B	N/A	-61.90%	-72.46%	-35.50%	-2.54	4.21	97.60%	-784.00%	-735.60%
ZYME	ZYMEWORKS INC	$1.83B	-37.80%	-25.20%	-23.03%	-31.60%	1.92	10.82	100.00%	-126.30%	-125.40%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$2.28B	10.30%	5.50%	8.89%	20.80%	0.85	3.57	54.70%	17.50%	27.54%
MOBI	MOBIA MEDICAL INC	N/A	N/A	N/A	-119.99%	N/A	-0.13	4.54	81.10%	-145.10%	-142.08%
DARE	DARE BIOSCIENCE INC	$36.10M	N/A	-46.20%	-179.16%	113.60%	36.89	1.03	53.50%	-1,038.80%	-1,038.77%
LEGN	LEGEND BIOTECH CORP	$5.20B	-24.90%	-14.90%	-19.75%	-31.30%	0.65	2.13	55.00%	-22.00%	-18.86%
GMRS	GMR SOLUTIONS INC	N/A	N/A	N/A	11.52%	N/A	33.47	2.00	38.90%	3.60%	12.88%
AGIO	AGIOS PHARMACEUTICALS INC	$1.71B	-34.10%	-31.70%	-37.62%	-35.00%	0.07	14.19	90.00%	-639.80%	-641.38%
NBTX	NANOBIOTIX SA	$1.95B	N/A	-35.50%	-85.10%	-27.90%	-1.80	1.09	100.00%	-73.50%	-26.77%
ESTA	ESTABLISHMENT LABS HOLDINGS INC	$2.10B	-225.90%	-12.70%	-9.27%	-5.80%	22.75	2.96	70.10%	-19.10%	-10.82%
DNTH	DIANTHUS THERAPEUTICS INC	$4.90B	-27.30%	-25.90%	-14.37%	-38.00%	0.04	29.25	100.00%	-12,998.50%	-12,998.50%
MAZE	MAZE THERAPEUTICS INC	$1.43B	-36.60%	-31.80%	-30.54%	-78.90%	0.23	17.88	100.00%	-612.70%	-608.38%
TWST	TWIST BIOSCIENCE CORP	$3.66B	-17.50%	-12.50%	-14.48%	-20.30%	0.49	2.70	52.10%	-19.80%	-19.67%
MGTX	MEIRAGTX HOLDINGS PLC	$878.86M	N/A	-55.00%	-158.37%	-83.30%	-5.21	0.55	95.40%	-151.10%	-136.08%
WVE	WAVE LIFE SCIENCES LTD	$1.24B	-56.80%	-42.80%	-34.40%	931.70%	0.14	11.26	100.00%	-255.70%	-255.70%
AGL	AGILON HEALTH INC	$1.34B	-138.60%	-23.30%	-148.97%	-411.50%	7.30	1.04	-2.50%	-6.10%	-5.95%
SNDX	SYNDAX PHARMACEUTICALS INC	$1.75B	-256.70%	-45.20%	-53.21%	-31.60%	10.36	5.47	96.00%	-111.90%	-94.59%
ATR	APTARGROUP INC	$7.37B	14.40%	7.60%	13.32%	19.70%	0.93	1.66	36.70%	10.00%	13.88%
PRGO	PERRIGO CO PLC	$1.57B	-50.70%	-19.80%	-22.56%	-25.20%	2.20	2.72	34.20%	-43.50%	-37.71%
HYFT	MINDWALK HOLDINGS CORP	$71.94M	-63.70%	-36.50%	-67.58%	-72.80%	0.55	3.74	60.30%	-66.50%	-65.87%
GEHC	GE HEALTHCARE TECHNOLOGIES INC	$29.26B	18.70%	5.20%	10.28%	16.00%	2.46	1.22	39.10%	9.10%	14.01%
COAG	HEMAB THERAPEUTICS HOLDINGS INC	$1.23B	N/A	N/A	N/A	N/A	-0.07	12.85	N/A	N/A	N/A
QNCX	QUINCE THERAPEUTICS INC	$17.44M	N/A	-38.10%	-197.19%	-215.70%	0.70	2.92	N/A	N/A	N/A
QTTB	Q32 BIO INC	$93.26M	230.70%	53.30%	62.72%	217.40%	0.38	5.36	100.00%	61.90%	61.86%
MXCT	MAXCYTE INC	$113.55M	-22.00%	-18.80%	-21.23%	-20.10%	0.16	12.04	80.50%	-121.20%	-121.16%
AXSM	AXSOME THERAPEUTICS INC	$12.02B	-260.00%	-27.80%	-66.88%	-125.30%	12.07	1.39	92.60%	-26.60%	-25.91%
HCAT	HEALTH CATALYST INC	$95.32M	-99.80%	-50.10%	-81.15%	-99.80%	1.98	1.69	49.90%	-87.70%	-81.71%
PHAT	PHATHOM PHARMACEUTICALS INC	$923.57M	N/A	-59.70%	-50.79%	-16.70%	-1.91	2.21	84.90%	-76.80%	-44.64%
KPTI	KARYOPHARM THERAPEUTICS INC	$182.66M	N/A	-176.90%	-1,045.36%	-88.40%	-1.50	1.08	96.00%	-129.00%	-97.64%
ATAI	ATAIBECKLEY INC	$1.59B	-366.50%	-269.00%	-276.34%	-390.80%	0.33	10.02	100.00%	-19,019.40%	-19,007.28%
LONA	LEONABIO INC	$94.59M	-381.00%	-225.70%	-199.33%	-1,888.60%	0.45	10.38	N/A	N/A	N/A
RAPP	RAPPORT THERAPEUTICS INC	$1.76B	-24.80%	-23.40%	-22.36%	-31.20%	0.06	27.08	100.00%	-536.40%	-536.39%
RIGL	RIGEL PHARMACEUTICALS INC	$540.08M	147.00%	99.30%	31.05%	49.00%	0.26	2.62	93.40%	121.50%	42.99%
IOVA	IOVANCE BIOTHERAPEUTICS INC	$1.65B	-50.20%	-38.80%	-44.55%	-92.90%	0.28	3.61	36.70%	-123.90%	-124.21%
CRMD	CORMEDIX INC	$632.32M	50.40%	27.40%	27.34%	86.10%	0.87	2.98	85.80%	45.20%	46.94%
LYEL	LYELL IMMUNOPHARMA INC	$403.68M	-85.70%	-66.40%	-78.55%	-87.90%	0.28	7.24	100.00%	-849,675.90%	-849,675.86%
MESO	MESOBLAST LTD	$1.93B	-18.20%	-13.10%	-10.17%	-72.20%	0.36	1.58	80.50%	-144.30%	-101.79%
INSP	INSPIRE MEDICAL SYSTEMS INC	$1.29B	18.00%	15.30%	7.80%	9.40%	0.15	6.34	85.80%	14.30%	7.00%
TLSI	TRISALUS LIFE SCIENCES INC	$211.89M	N/A	-125.50%	-36.38%	-57.00%	4.54	5.78	85.10%	-128.70%	-47.98%
PDSB	PDS BIOTECHNOLOGY CORP	$64.75M	-346.00%	-102.40%	-199.49%	-237.90%	5.34	2.26	N/A	N/A	N/A
CDXS	CODEXIS INC	$229.97M	-68.10%	-23.70%	-23.36%	-18.10%	1.99	5.36	88.90%	-41.00%	-34.26%
ACAD	ACADIA PHARMACEUTICALS INC	$3.65B	35.60%	26.20%	8.86%	14.50%	0.29	3.59	91.50%	34.30%	10.51%
FATE	FATE THERAPEUTICS INC	$244.77M	-58.90%	-39.40%	-51.10%	-39.90%	0.59	5.85	100.00%	-2,056.80%	-2,056.79%
HCM	HUTCHMED (CHINA) LTD	$2.10B	45.70%	30.20%	36.41%	45.60%	0.41	4.96	38.70%	83.30%	95.42%
LXEO	LEXEO THERAPEUTICS INC	$410.67M	-47.50%	-41.70%	-37.01%	-61.60%	0.08	14.16	N/A	N/A	N/A
ALXO	ALX ONCOLOGY HOLDINGS INC	$267.78M	-124.10%	-85.60%	-55.23%	-128.90%	0.18	7.21	N/A	N/A	N/A
CMPS	COMPASS PATHWAYS PLC	$1.56B	-150.90%	-55.40%	-46.77%	344.50%	0.63	3.32	N/A	N/A	N/A
DOCS	DOXIMITY INC	$3.55B	19.40%	16.50%	25.81%	31.90%	0.18	6.09	89.10%	30.40%	38.77%
EMBC	EMBECTA CORP	$196.97M	-17.50%	10.30%	34.40%	13.40%	-2.64	2.46	61.90%	10.70%	25.80%
AVLN	AVALYN PHARMA INC	N/A	N/A	N/A	-63.21%	N/A	-0.06	10.19	N/A	N/A	N/A
CRBU	CARIBOU BIOSCIENCES INC	$197.37M	-100.10%	-72.00%	-103.44%	-78.30%	0.46	6.22	100.00%	-1,512.80%	-1,519.07%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$82.56M	-29.30%	-10.50%	-18.97%	-28.50%	2.30	0.95	82.90%	-17.60%	-16.52%
ACET	ADICET BIO INC	$73.76M	-80.40%	-65.40%	-72.00%	-87.30%	0.21	7.66	N/A	N/A	N/A
ALMR	ALAMAR BIOSCIENCES INC	$1.52B	N/A	N/A	N/A	N/A	-0.73	5.88	N/A	N/A	N/A
QURE	UNIQURE NV	$1.56B	-145.80%	-27.20%	-19.78%	-16.30%	4.21	10.40	90.60%	-1,154.40%	-786.66%
ITGR	INTEGER HOLDINGS CORP	$3.06B	8.20%	4.20%	6.14%	7.70%	1.01	3.76	26.40%	7.60%	10.61%
SRZN	SURROZEN INC	$314.52M	N/A	-346.50%	-324.35%	-3,450.40%	-1.43	11.91	100.00%	-4,810.50%	-4,810.50%
SIGA	SIGA TECHNOLOGIES INC	$337.82M	10.60%	8.90%	17.45%	92.40%	0.45	3.25	65.40%	21.60%	28.69%
CHRS	COHERUS ONCOLOGY INC	$242.17M	214.60%	50.30%	146.09%	9,214.60%	2.38	1.56	68.10%	397.30%	416.58%
NGEN	NERVGEN PHARMA CORP	$298.05M	N/A	N/A	N/A	N/A	2.75	1.34	N/A	N/A	N/A
SGMT	SAGIMET BIOSCIENCES INC	$428.29M	-37.60%	-35.50%	-42.47%	-54.90%	0.05	20.34	N/A	N/A	N/A
CTKB	CYTEK BIOSCIENCES INC	$511.40M	-20.80%	-15.60%	-9.90%	-12.30%	0.37	4.69	51.70%	-36.20%	-17.85%
DOMH	DOMINARI HOLDINGS INC	$73.04M	-47.50%	-35.60%	N/A	-24.50%	1.70	N/A	100.00%	-31.40%	-17.98%
RLMD	RELMADA THERAPEUTICS INC	$756.26M	-71.20%	-64.50%	-26.47%	-73.70%	0.08	18.26	N/A	N/A	N/A
PACB	PACIFIC BIOSCIENCES OF CALIFORNIA INC	$388.25M	-488.40%	-16.10%	-16.85%	-11.60%	329.67	5.65	37.50%	-80.30%	-75.50%
GRDX	GRIDAI TECHNOLOGIES CORP	$28.58M	-82.80%	-7.20%	-18.87%	-16.70%	1.00	0.17	-1,813.60%	-17,634.40%	-17,380.36%
NXTC	NEXTCURE INC	$36.84M	-190.20%	-124.60%	-175.85%	-218.70%	0.42	4.61	N/A	N/A	N/A
MENS	JYONG BIOTECH LTD	$158.14M	N/A	N/A	15.19%	N/A	-1.83	0.45	N/A	N/A	N/A
TDOC	TELADOC HEALTH INC	$1.19B	-12.40%	-6.00%	-6.90%	-14.40%	1.10	2.80	69.30%	-6.80%	-6.59%
MRNA	MODERNA INC	$18.75B	-36.70%	-26.60%	-34.51%	-33.60%	0.55	2.41	22.10%	-143.60%	-141.03%
CAMP	CAMP4 THERAPEUTICS CORP	$228.47M	-194.70%	-95.60%	-97.15%	-12,049.00%	2.41	6.15	100.00%	-2,193.70%	-2,193.72%
MDGL	MADRIGAL PHARMACEUTICALS INC	$11.84B	-50.20%	-25.40%	-31.79%	-29.40%	1.26	3.50	93.10%	-27.30%	-24.95%
NVCT	NUVECTIS PHARMA INC	$290.19M	-161.00%	-98.90%	-191.00%	238.90%	0.79	2.27	N/A	N/A	N/A
PRVA	PRIVIA HEALTH GROUP INC	$2.85B	3.00%	1.60%	4.83%	-148.20%	0.81	1.61	10.00%	1.00%	1.76%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$139.43M	N/A	-1,168.70%	273.68%	323.40%	-1.25	0.13	N/A	N/A	N/A
INKT	MINK THERAPEUTICS INC	$54.50M	N/A	-118.60%	-403.62%	182.80%	-1.82	1.38	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	602	+0.98%	-2.57%	-1.90%	-76.05%	18.28x	4.87x	-122.61%	-12.79%	-9.65%	+63.30%	Strong Buy
Diagnostics & Research	55	+0.67%	+2.81%	-8.17%	+10.83%	15.48x	3.33x	-6.63%	+6.21%	+12.47%	+27.83%	Strong Buy
Drug Manufacturers - General	20	+1.56%	+1.86%	+5.32%	+34.81%	35.69x	7.08x	+34.51%	+12.30%	+21.70%	+16.21%	Buy
Drug Manufacturers - Specialty & Generic	75	+1.45%	+0.08%	-0.21%	-29.54%	10.90x	1.56x	+9.35%	+5.09%	+10.99%	+40.37%	Buy
Healthcare Plans	10	-0.67%	-2.56%	+17.39%	-0.56%	26.31x	2.31x	+9.02%	+2.82%	+6.93%	+0.78%	Buy
Health Information Services	53	-0.32%	+2.09%	+1.61%	-27.61%	18.03x	2.95x	-3.94%	+0.71%	+1.12%	+39.60%	Buy
Medical Care Facilities	50	-0.91%	-2.48%	+4.38%	-21.64%	15.15x	4.82x	-49.93%	+6.78%	+15.36%	+22.72%	Buy
Medical Devices	139	+0.14%	+3.57%	-2.51%	-69.30%	23.09x	3.04x	+6.44%	+5.41%	+9.00%	+33.12%	Strong Buy
Medical Distribution	10	+1.07%	+2.30%	-9.07%	+5.35%	22.37x	143.42x	-104.83%	+3.78%	+25.68%	+28.40%	Buy
Medical Instruments & Supplies	55	+0.20%	+3.38%	-1.50%	-5.73%	42.68x	3.27x	+7.01%	+7.29%	+10.77%	+27.03%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 47, which is 20 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 42.55% over the past year, overperforming other healthcare stocks by 102 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 57.98% from Bioventus's current stock price of $9.50.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 34, which is 7 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 122.45% over the past year, overperforming other healthcare stocks by 181 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $251.09, an upside of 4.88% from Jazz Pharmaceuticals's current stock price of $239.40.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 72.73% have issued a Strong Buy rating, 27.27% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior Pharmaceuticals (NASDAQ:INDV)

Indivior Pharmaceuticals (NASDAQ:INDV) is the #3 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior Pharmaceuticals (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior Pharmaceuticals (NASDAQ:INDV) has a Due Diligence Score of 41, which is 14 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Indivior Pharmaceuticals has seen its stock return 234.79% over the past year, overperforming other healthcare stocks by 294 percentage points.

Indivior Pharmaceuticals has an average 1 year price target of $48.00, an upside of 28.14% from Indivior Pharmaceuticals's current stock price of $37.46.

Indivior Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Indivior Pharmaceuticals, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 75 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

Cryo Cell International's dividend payout ratio of -45.5% indicates that its dividend yield might not be sustainable for the long-term.

2. So Young International (NASDAQ:SY)

So Young International (NASDAQ:SY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

So Young International's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 30.19%, which is 28 percentage points higher than the healthcare sector average of 2.66%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.58% in the last day, and up 0.01% over the last week. Akari Therapeutics was the among the top gainers in the healthcare sector, gaining 255.45% yesterday.

Akari Therapeutics shares are trading higher after the company announced preclinical data demonstrating synergistic activity of AKTX-101 with KRAS inhibition in KRAS-mutated pancreatic cancer models

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 42 points higher than the healthcare sector average of 15. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -68.4% in the past year. It has underperformed other stocks in the healthcare sector by -9 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 71 points higher than the healthcare sector average of 15. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 532.26% in the past year. It has overperformed other stocks in the healthcare sector by 591 percentage points.

3. Auna Sa (NYSE:AUNA)

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 43, which is 28 points higher than the healthcare sector average of 15. It passed 3 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -36.8% in the past year. It has overperformed other stocks in the healthcare sector by 22 percentage points.

Are healthcare stocks a good buy now?

60.49% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.89% over the next year.

4.95% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.38% of healthcare stocks are rated B (Buy), 48.14% are rated C (Hold), 27.48% are rated D (Sell), and 7.05% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.77x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. Cryo Cell International (NYSEMKT:CCEL)

2. So Young International (NASDAQ:SY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. Cryo Cell International (NYSEMKT:CCEL)

2. So Young International (NASDAQ:SY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.